Concepedia

Carylinda Serna

CS

6

Publications

219

Citations

6

H-Index

2014

Active since

Affiliations

National Institutes of Health(Current)

Center for Cancer Research

National Cancer Institute

Carylinda Serna is an author at National Institutes of Health specializing in immunotherapy, immunodominance, and parasitology.

Top concepts

Publications per year

2014–2023

6

Publications

6

A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease

Carylinda Serna, Joshua A. Lara, Silas P. Rodrigues et al. · Vaccine · 2014 · 60 citations · Full text

, , +12

Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models

Ling Zhang, John Davies, Carylinda Serna et al. · Journal for ImmunoTherapy of Cancer · 2020 · 51 citations · Full text

A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging

Erica Silberstein, Carylinda Serna, Stênio Perdigão Fragoso et al. · PLoS ONE · 2018 · 39 citations · Full text

Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1

Bridget C. Marcinkowski, Sanja Stevanović, Sarah R. Helman et al. · Journal for ImmunoTherapy of Cancer · 2019 · 39 citations · Full text

Non-synergy of PD-1 blockade with T-cell therapy in solid tumors

John Davies, Farrah Karimipour, Ling Zhang et al. · Journal for ImmunoTherapy of Cancer · 2022 · 17 citations · Full text

Rows per page

1–5 of 6